glp 1 drug novo nordisk With FDA approval of Wegovy pill, new era of oral GLP-1 weight loss drugs begins GLP-1s for Alzheimer's: Novo Nordisk

IGF-1 LR3 (1 mg) is a synthetic recombinant analog of insulin-like growth factor-1 (IGF-1), categorized under growth factor and muscle biology research peptides, and supplied exclusively for laboratory research use

This paper serves as a call to action for the food science community to embrace this paradigm shift and dedicate resources to further explore the vast, and largely untapped, potential of dietary hormesis

Many people live with low-grade chronic inflammation for years without realizing its the root cause of their ongoing physical challenges

High triglyceride concentration in the blood (hypertriglyceridemia) is associated with an increased risk of developing atherosclerosis and an increased risk of coronary heart disease (CHD)

Calandrella, N., De, Seta C., Scarsella, G., and Risuleo, G